US gives full approval to Moderna’s COVID-19 vaccine
2 years, 10 months ago

US gives full approval to Moderna’s COVID-19 vaccine

Associated Press  

WASHINGTON — U.S. health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of millions of Americans since its emergency authorization over a year ago. The FDA granted full approval of Pfizer’s vaccine last August. “The public can be assured that this vaccine was approved in keeping with the FDA’s rigorous scientific standards,” said Dr. Peter Marks, FDA’s top vaccine regulator, in a statement. Also Monday, Novavax Inc. formally requested FDA authorization of a different type of COVID-19 vaccine, in hopes of becoming the fourth U.S. option.

Covid Approval Fda Vaccine Moderna Full Approval  health  vaccine  moderna  covid19  type  million  gives  approval  modernas  fda  vaccinations  shot

History of this topic

The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
1 week, 4 days ago

The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind

CNN  

A version of this story appeared in CNN Business’ Nightcap newsletter. Moderna’s Covid vaccine remains the primary driver of its revenue, and its other vaccine, one for RSV, is “not likely to be a major player.” Unsurprisingly, then, the short-sellers are piling in hard. “Moderna’s declining stock price, rising short interest, and increased implied volatility reveal an evolving risk narrative,” …

FDA approves updated COVID-19 vaccines; shots should be available in days
4 months ago

FDA approves updated COVID-19 vaccines; shots should be available in days

LA Times  

With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses of the new COVID019 vaccine. U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter too. “We strongly encourage those who are eligible to consider receiving …

Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health
6 months, 1 week ago

Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health

New Indian Express  

Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. The control groups received a COVID vaccine and a suitable flu vaccine delivered separately. The control group in the 50-to-64 age category were given the Fluarix flu vaccine, as well as Moderna’s mRNA COVID vaccine, Spikevax. The over-65 control …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
6 months, 2 weeks ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection
1 year, 2 months ago

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection

Salon  

On Tuesday, the Food and Drug Administration authorized the use of a new Novavax vaccine specifically targeted to protect against the latest Omicron circulating strains. Following a bumpy rollout of the Moderna and Pfizer vaccines, it will bring another option to the table for those who are ready to roll up their sleeves and get vaccinated amid a rise in …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 3 months ago

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots

India Today  

The U.S. Food and Drug Administration on Monday authorized updated Covid-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign. Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available …

U.S. approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago

U.S. approves updated COVID vaccines to rev up protection this fall

The Hindu  

The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter. It’s part of a shift to treat fall updates of the COVID-19 vaccine much like getting a yearly flu shot. “Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including …

US approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago

US approves updated COVID vaccines to rev up protection this fall

Associated Press  

WASHINGTON — The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter. It’s part of a shift to treat fall updates of the COVID-19 vaccine much like getting a yearly flu shot. “Vaccination remains critical to public health and continued protection against serious consequences of …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

FDA approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago

FDA approves updated COVID vaccines to rev up protection this fall

LA Times  

Single-dose vials of Pfizer’s updated COVID vaccine for adults, which was approved by U.S. regulators on Monday. The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter. “Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death,” …

Moderna says updated COVID vaccine is effective against ‘highly-mutated’ BA.2.86 variant
1 year, 3 months ago

Moderna says updated COVID vaccine is effective against ‘highly-mutated’ BA.2.86 variant

Hindustan Times  

Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections. The Omicron offshoot carries more than 35 mutations in key portions of the virus compared with XBB.1.5, the dominant variant through most of 2023 and the target …

Extra COVID-19 booster now open to some high-risk Americans
1 year, 8 months ago

Extra COVID-19 booster now open to some high-risk Americans

Associated Press  

WASHINGTON — Older Americans and people with weak immune systems can get an extra COVID-19 booster dose this spring. From now on, anyone getting a Pfizer or Moderna dose — whether it’s a booster or their first-ever vaccination — will get an updated version rather than the outdated original shots. People 65 or older who already had one Pfizer or …

NOT REAL NEWS: A look at what didn't happen this week
1 year, 9 months ago

NOT REAL NEWS: A look at what didn't happen this week

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. “We are obviously providing financial assistance — budgetary …

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit
1 year, 10 months ago

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit

Associated Press  

Moderna’s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment. Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its Spikevax coronavirus preventive shots. Researchers are testing how Moderna’s potential vaccine and Merck’s immunotherapy Keytruda work in improving …

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them
1 year, 11 months ago

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them

LA Times  

Doses of the Moderna COVID-19 vaccine wait to be administered at a clinic. That included a research grant of almost $1 billion from the government’s Biomedical Advanced Research and Development Authority, or BARDA, through 2020, plus a $1.5-billion federal purchase guarantee in 2020 for COVID vaccines before testing was even completed — a deal that materially reduced Moderna’s financial risks …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

Pfizer asks FDA to clear updated COVID shot for kids under 5
2 years ago

Pfizer asks FDA to clear updated COVID shot for kids under 5

LA Times  

A nurse in Seattle gives a dose of Pfizer’s original COVID-19 vaccine shot to a 20-month-old child in June. Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for the initial series of shots for children under age 5. Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 — not as …

US renews push for COVID boosters as data show they protect
2 years, 1 month ago

US renews push for COVID boosters as data show they protect

Associated Press  

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday. Speaking at a White House briefing expected to be his last before he retires from the government at the end of year, Fauci said what “may be the final message I give …

U.S. clears Novavax vaccine for use as COVID-19 booster
2 years, 2 months ago

U.S. clears Novavax vaccine for use as COVID-19 booster

LA Times  

A vial of the COVID-19 vaccine made by Novavax. U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the Omicron-targeting boosters from Pfizer-BioNTech or Moderna for medical or accessibility reasons — or who otherwise would …

EMA gives positive advice over Covid-19 vaccines for children from 6 months
2 years, 2 months ago

EMA gives positive advice over Covid-19 vaccines for children from 6 months

NL Times  

The European Medicines Agency advised the European Commission to approve the Covid-19 vaccines produced by Pfizer and Moderna for use in children from six months old. Currently, Pfizer's vaccine is only allowed for children once they reach five years of age, and the Moderna vaccine can be given to children as young as six years old. Children from six months …

Moderna will not bow to China’s coercion, refuses to give COVID-19 vaccine recipe over ‘safety’ concerns
2 years, 2 months ago

Moderna will not bow to China’s coercion, refuses to give COVID-19 vaccine recipe over ‘safety’ concerns

Firstpost  

China hasn’t approved any foreign vaccine and has been insisting on sharing the technology behind the Moderna vaccine as a prerequisite for allowing its sale in the country New Delhi: American pharma company Moderna has refused to accept China’s condition to share the technology behind its COIVD-19 vaccine as a prerequisite for approving it citing ‘safety’ concerns, derailing the negotiations …

Pfizer seeks EMA approval to give modified Covid vaccine jabs to children
2 years, 2 months ago

Pfizer seeks EMA approval to give modified Covid vaccine jabs to children

NL Times  

The makers of the Comirnaty Covid-19 vaccine want their modified version of the vaccine to be approved for use by children from 5 to 11 years of age in the European market. The new version has been adapted to prevent serious symptoms of Covid-19 caused by infection from newer variants of the SARS-CoV-2 coronavirus. This week, Comirnaty producers Pfizer and …

Pfizer, Moderna seek authorization for updated Covid-19 boosters for younger children
2 years, 2 months ago

Pfizer, Moderna seek authorization for updated Covid-19 boosters for younger children

CNN  

CNN — Younger children could soon be eligible to receive an updated Covid-19 booster shot. Pfizer and BioNTech on Monday said they completed their submission to the US Food and Drug Administration for emergency use authorization of their updated Covid-19 booster for children ages 5 through 11. Moderna on Friday said it had requested FDA authorization for its updated booster …

UK Approves Pfizer Bivalent Covid Vaccine Ahead of Booster Drive
2 years, 3 months ago

UK Approves Pfizer Bivalent Covid Vaccine Ahead of Booster Drive

News 18  

The UK’s drug regulator said Saturday it had approved an updated Covid-19 jab by Pfizer/BioNTEch targeting the original virus and a subvariant ahead of an autumn booster drive. The UK Medicines and Healthcare products Regulatory Agency approved the Pfizer jab as a booster for those aged 12 and over after a “careful review of the evidence”. MHRA chief executive June …

US CDC endorses updated Covid boosters, shots to begin soon
2 years, 3 months ago

US CDC endorses updated Covid boosters, shots to begin soon

India Today  

The US Centers for Disease Control and Prevention on Thursday endorsed updated Covid-19 boosters, opening the way for a fall vaccination campaign that could blunt a winter surge if enough Americans roll up their sleeves. The CDC’s advisers struggled with who should get the new boosters and when because only a similarly tweaked vaccine, not the exact recipe, has been …

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine
2 years, 3 months ago

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine

The Hindu  

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. The U.S. Food and Drug Administration granted emergency use authorization for the COVID-19 vaccine first to Pfizer/BioNTech in December 2020, then one week later …

Moderna Sues Pfizer, BioNTech For Patent Infringement Over Its mRNA Covid Vaccine
2 years, 3 months ago

Moderna Sues Pfizer, BioNTech For Patent Infringement Over Its mRNA Covid Vaccine

ABP News  

Moderna said on Friday it was suing Pfizer and and its German partner BioNTech for copying the "groundbreaking technology" behind its mRNA Covid-19 vaccine. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the company said in a statement. "Moderna expects Pfizer and BioNTech to compensate Moderna …

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement
2 years, 3 months ago

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement

News 18  

Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot that has been administered to hundreds of millions around the world. “Moderna believes that Pfizer and BioNTech’s Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna’s foundational mRNA technology,” the company said …

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement
2 years, 3 months ago

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement

India Today  

Moderna said on Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the US-based biotech firm said …

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine
2 years, 3 months ago

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine

Live Mint  

American pharmaceutical and biotechnology company Moderna has filed a suit in a United States District court against Pfizer and its German partner BioNTech, seeking undetermined damages for patent infringement in the development of the first Covid-19 vaccine. Moderna in a press release informed that they are seeking undetermined monetary damages in the lawsuit filed in the U.S. District Court in …

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech
2 years, 3 months ago

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech

Al Jazeera  

Moderna previously pledged not to enforce COVID-19-related patents but changed its stance as the pandemic shifted gears. Moderna has said it is suing rival vaccine maker Pfizer and its German partner BioNTech, citing infringement on its patents in developing the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. “Moderna …

Omicron-targeted COVID vaccine gets approval: All you need to know
2 years, 4 months ago

Omicron-targeted COVID vaccine gets approval: All you need to know

Live Mint  

Late last year, the Omicron COVID variant was first spotted in South Africa and within months, it became the dominant coronavirus strain the world over. Owing to this, the experts have been working on an Omicron-specific vaccine that became a reality recently with Moderna Inc. receiving approval from the UK government for a Covid-19 booster shot that targets omicron. The …

British regulator 1st to OK Moderna’s updated COVID booster
2 years, 4 months ago

British regulator 1st to OK Moderna’s updated COVID booster

Associated Press  

LONDON — British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that includes protection against the omicron variant, which the government said would be offered to people aged 50 and over starting in the fall. In a statement on Monday, the Medicines and Healthcare Regulatory Agency said it had given …

British regulator 1st to OK Moderna’s updated booster that targets Omicron
2 years, 4 months ago

British regulator 1st to OK Moderna’s updated booster that targets Omicron

LA Times  

A vial of Moderna’s original COVID-19 vaccine. In a statement Monday, the Medicines and Healthcare Regulatory Agency said it had given the green light to Moderna’s combination “bivalent” vaccine, which will be used as an adult booster shot. British regulators said the side effects were similar to those seen for Moderna’s original booster shot and were typically “mild and self-resolving.” …

CDC endorses more traditional Novavax COVID shot for adults
2 years, 5 months ago

CDC endorses more traditional Novavax COVID shot for adults

Associated Press  

U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax -- a more traditional kind of vaccine, health officials said Tuesday. THE NOVAVAX DIFFERENCE All of the vaccines used in the U.S. train the body to fight the coronavirus by recognizing its outer coating, the spike protein -- and the first three options essentially …

The CDC endorses Novavax, a more traditional COVID vaccine, for adults
2 years, 5 months ago

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

NPR  

The CDC endorses Novavax, a more traditional COVID vaccine, for adults Enlarge this image toggle caption Georg Wendt/AP Georg Wendt/AP U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the …

CDC endorses more traditional Novavax COVID-19 shot
2 years, 5 months ago

CDC endorses more traditional Novavax COVID-19 shot

LA Times  

A dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use. U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the body to fight the …

US regulators OK new COVID-19 shot option from Novavax
2 years, 5 months ago

US regulators OK new COVID-19 shot option from Novavax

Associated Press  

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries. Novavax also has submitted data on booster …

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 5 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

FDA advisers recommend updating COVID booster shots for fall
2 years, 5 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA advisors recommend updating COVID booster shot formula for fall
2 years, 5 months ago

FDA advisors recommend updating COVID booster shot formula for fall

LA Times  

Advisors to the Food and Drug Administration are recommending that some U.S. adults get a modified COVID-19 booster shot this fall that better matches the recent variants. Some U.S. adults are a step closer to getting updated COVID-19 boosters this fall, as government advisors voted Tuesday that it’s time to tweak the shots to better match the most recent virus …

FDA grapples with whether to modify COVID vaccine for fall
2 years, 5 months ago

FDA grapples with whether to modify COVID vaccine for fall

LA Times  

The Food and Drug Administration will debate Tuesday whether it’s time to update COVID vaccine formulas. “This is science at its toughest,” said FDA vaccine chief Dr. Peter Marks, adding that a final decision is expected within days of the advisory panel’s recommendation. In an analysis prepared for Tuesday’s meeting, FDA officials acknowledged targeting last winter’s version of Omicron is …

Experts endorse Moderna COVID-19 shots for kids ages 6 to 17
2 years, 6 months ago

Experts endorse Moderna COVID-19 shots for kids ages 6 to 17

Associated Press  

NEW YORK — An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17 Thursday. Advisers to the U.S. Centers for Disease Control and Prevention voted unanimously to recommend Moderna shots as an option for school-age kids and adolescents. Last week, the Food and Drug Administration authorized the shots — full-strength doses for children ages 12 …

US to roll out COVID vaccines for youngest children next week
2 years, 6 months ago

US to roll out COVID vaccines for youngest children next week

Al Jazeera  

US to begin vaccinating children as young as six months after CDC clears Pfizer-BioNTech and Moderna’s shots for infants, toddlers and preschoolers. The United States Centers for Disease Control and Prevention has approved COVID-19 vaccines for children as young as six months, allowing a nationwide rollout to start next week. The US Food and Drug Administration on Friday authorized Moderna …

FDA authorizes 1st COVID-19 shots for infants, preschoolers
2 years, 6 months ago

FDA authorizes 1st COVID-19 shots for infants, preschoolers

Associated Press  

U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The FDA also authorized Moderna’s vaccines for school-aged children and teens; CDC’s review is next week. While young children generally don’t get as sick from COVID-19 as older kids and adults, their hospitalizations surged during the omicron wave …

When Will It Be Time For Another COVID Booster? Here's What Experts Think.
2 years, 6 months ago

When Will It Be Time For Another COVID Booster? Here's What Experts Think.

Huff Post  

LOADING ERROR LOADING We’ve seen second COVID-19 boosters recommended for older adults and people with underlying health conditions — but what about the general population? Immunocompromised individuals and older people’s antibody levels wane earlier, which makes these people strong candidates for booster doses, said Arjun Venkatesh, a Yale Medicine emergency medicine doctor and associate professor at Yale School of Medicine. …

US Approves Pfizer, Moderna Covid-19 Vaccines for Youngest Children
2 years, 6 months ago

US Approves Pfizer, Moderna Covid-19 Vaccines for Youngest Children

News 18  

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries. The agency authorized Moderna’s two-dose vaccine for children aged six months to five years, and three doses of Pfizer’s shots for those between six months and four years …

Covid Vaccines For Children Under-Five Received US FDA Nod
2 years, 6 months ago

Covid Vaccines For Children Under-Five Received US FDA Nod

News 18  

A panel of experts convened by the US Food and Drug Administration unanimously recommended Covid-19 vaccines Wednesday for children under five, the final age group awaiting immunization in most countries. Opening the discussion, senior FDA scientist Peter Marks said that despite studies showing the majority of children have now been infected with the coronavirus, the high rate of hospitalizations among …

Discover Related